OBJECTIVE	This trial aimed to compare the blood glucose-lowering effect of insulin detemir with that of NPH insulin ( NPH ) and to evaluate the two treatments with regard to intrasubject variation of fasting blood glucose , incidence of hypoglycemia , dose requirements , and safety .\